主要10センサーの世界市場予測（～2022）：種類別（圧力、温度、画像、モーション、指紋、レベル、ガス、磁場、ポジション、ライト）、技術別、用途別、需要先産業別、地域別...市場調査レポートについてご紹介

1 Introduction (Page No. – 16)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 20)
2.1 Research Methodology
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.1.1 Key Data From Secondary Sources
2.2.2 Primary Research
2.2.2.1 Key Data From Primary Sources
2.2.2.2 Key Insights From Primary Sources
2.2.2.3 Key Industry Insights
2.3 Market Size Estimation Methodology
2.4 Market Forecast Methodology
2.5 Market Data Validation and Triangulation
2.6 Assumptions for the Study

3 Executive Summary (Page No. – 30)
3.1 Introduction
3.2 Conclusion

4 Premium Insights (Page No. – 36)
4.1 Humanized Mouse Model: Market Overview
4.2 Regional Analysis: Global Market, By End User
4.3 Global Market, By Application, 2016 vs 2021
4.4 Regional Snapshot: Global Market

5 Market Overview (Page No. – 39)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Surge in the Number of Research Activities Involving Humanized Mouse Models
5.2.1.1.1 Mice Models for Immunodeficiency Disorders
5.2.1.1.2 Mice Models for Cancer
5.2.1.1.3 Mice Models for Rare Diseases
5.2.1.2 Growing Adoption of Personalized Medicine to Fuel the Demand for Personalized Mice Models
5.2.1.3 Continuous Support in the Form of Investments and Grants From the Government and Private Sectors
5.2.1.3.1 Funding/Grants By the National Institutes of Health (NIH)
5.2.1.3.2 Funding/Grants Received From Other Government Bodies
5.2.1.4 Increase in R&D Activities Carried Out By Pharmaceutical and Biotechnology Companies
5.2.2 Restraints
5.2.2.1 Regulations & Laws Formulated for Ethical Use of Animals
5.2.2.1.1 The Animal Welfare Act (AWA)
5.2.2.1.2 Public Health Service (PHS) Policy on Humane Care and Use of Laboratory Animals
5.2.2.2 Increased Use of Rat Models
5.2.3 Opportunities
5.2.3.1 Increased Production of Monoclonal Antibodies
5.2.4 Challenges
5.2.4.1 Advances in Zebrafish Model Development
5.2.4.2 Alternative Methods of Animal Testing
5.2.4.3 Limitations of Humanized Mouse Models

6 Clinical Trials & Research Studies Assessment (Page No. – 49)
6.1 Introduction
6.2 Clinical Trials
6.3 Research Studies

7 Humanized Mouse Model Market, By Type (Page No. – 56)
7.1 Introduction
7.2 Genetic Humanized Mouse Model
7.3 Cell-Based Humanized Mouse Model
7.3.1 CD34 Humanized Mouse Model (Hu-CD34)
7.3.2 PBMC Humanized Mouse Model
7.3.3 BLT Humanized Mouse Model

8 Humanized Mouse Model Market, By Application (Page No. – 66)
8.1 Introduction
8.2 Oncology
8.2.1 Agreements/Collaborations to Strengthen Cancer Research
8.2.2 Continuous Grants/Funds to Support Cancer Research Studies
8.3 Immunology and Infectious Diseases
8.4 Neurosciences
8.4.1 Grants/Funds for Neurological Research
8.5 Toxicology
8.6 Hematopoiesis
8.7 Other Applications
8.7.1 Increasing Funding for Rare Disease Research

9 Humanized Mouse Model Market, By End User (Page No. – 78)
9.1 Introduction
9.2 Pharmaceutical & Biotechnology Companies
9.3 Contract Research Organizations
9.4 Academic & Research Institutions

10 Global Market, By Region (Page No. – 85)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.1.1 Availability of Support for Research in the U.S.
10.2.1.2 Preclinical Activities By Cros and Pharmaceutical R&D
10.2.1.3 Conferences and Other Events Contributing to the Spread of Innovation and Awareness
10.2.1.4 Growing Monoclonal Antibody Production
10.2.1.5 Development of Biosimilars Boosting the Demand for Preclinical Services
10.2.2 Canada
10.2.2.1 Growing Stem Cell Research in Canada
10.2.2.2 Government Support for Development of Protein Drugs
10.3 Europe
10.3.1 Launch of Pro-Test Deutschland in Germany
10.3.2 Flourishing Biotechnology Industry in Germany
10.3.3 Emphasis on Quality Research Results in the U.K.
10.3.4 Increase in Cell Therapy Preclinical Research in the U.K.
10.3.5 Funding for Rare Disease Projects in France
10.3.6 Growth in Biotech and Pharma Sector of Italy
10.3.7 Growing Investments in Research By Sweden & Denmark
10.4 Asia-Pacific
10.4.1 China: Strong Research Expenditure, Well-Structured Cro Industry
10.4.2 Mandatory Animal Testing for All Pharmaceutical Drugs and Cosmetics in China
10.4.3 Rising Focus on Personalized Medicine in China
10.4.4 Increasing Investments From Government and Private Sectors in China’s Life Sciences Sector
10.4.5 Japan: Government Support for Research, Growth in Biomedical and Medical Research
10.4.6 Research in Regenerative Medicine in Japan
10.4.7 Growth of the Pharmaceutical Industry in India
10.4.8 Development of Bio-Clusters to Boost India’s Biotechnology Sector
10.4.9 Infrastructural Limitations in India: A Key Hindrance for Market Growth
10.4.10 Ongoing Biomedical Research Activities in Australia
10.4.11 Growth in Translational and Biomedical Research in Singapore
10.4.12 Increase in Animal Research in Malaysia
10.4.13 Rising Pharmaceutical and Biotechnology R&D Activities in Korea
10.5 Rest of the World
10.5.1 Brazil: Growth in the Pharmaceutical, Biotechnology, and Research Industries
10.5.2 Favorable Business Environment for Pharmaceutical and Biotechnology Industries in Saudi Arabia and the UAE
10.5.3 Increasing Investments in Mexico

11 Competitive Landscape (Page No. – 119)
11.1 Overview
11.2 Market Share Analysis
11.2.1 Introduction
11.2.2 Cell-Based Humanized Mouse Model Market
11.2.2.1 The Jackson Laboratory (U.S.)
11.2.2.2 Taconic Biosciences, Inc. (U.S.)
11.2.3 Genetic Humanized Mouse Model Market
11.2.3.1 Horizon Discovery Group PLC (U.K.)
11.2.3.2 Taconic Biosciences, Inc. (U.S.)
11.3 Competitive Situation and Trends
11.4 Agreements, Collaborations, Contracts, Alliances, and Partnerships
11.5 Grant/Fund
11.6 Product Launches
11.7 Expansions
11.8 Acquisitions
11.9 Other Strategies

12 Company Profiles (Page No. – 132)
(Overview, Products and Services, Financials, Strategy & Development)*
12.1 Introduction
12.2 The Jackson Laboratory
12.3 Taconic Biosciences, Inc.
12.4 Horizon Discovery Group PLC
12.5 Genoway S.A.
12.6 Harbour Antibodies Bv (A Subsidiary of Harbour Biomed)
12.7 Humurine Technologies
12.8 Vitalstar Biotechnology Co., Ltd.
12.9 Ingenious Targeting Laboratory
12.10 Axenis S.A.S
12.11 Trans Genic, Inc.
12.12 Champions Oncology, Inc.
12.13 Crown Bioscience, Inc.

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. – 162)
13.1 Discussion Guide
13.2 Other Developments (2013–2016)
13.2.1 the Jackson Laboratory
13.2.2 Taconic Biosciences, Inc.
13.2.3 Horizon Discovery Group PLC
13.2.4 Genoway S.A.
13.2.5 Ingenious Targeting Laboratory
13.2.6 Trans Genic, Inc.
13.2.7 Champions Oncology, Inc.
13.2.8 Crown Bioscience, Inc.
13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports
13.7 Author Details